Zhongchao Inc Dossier
|
SectorConsumer Discretionary IndustryDiversified Consumer Services Beta (adjusted)0.30 Intrinsic Value Insufficient data for a value estimateNot enough reliable inputs to publish a fair value for this company yet. Market Price $0.86Price as of 30 Sep 2026 Data confidenceNot applicable Market Cap $7.7M Enterprise Value −$415.1K Shares Outstanding 8.9M diluted Moat Rating None Next Earnings Date30 Apr 2027 All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference. ThesisStreet consensus, scenarios, merits, risks, and invalidation triggers Thesis Summary Zhongchao Inc. (ZCMD) faces severe operational, financial, and regulatory headwinds. The company's FY 2025 revenue declined by 28% year-over-year to $11.37 million, while its net loss widened significantly to $6.31 million. To maintain its Nasdaq listing, the company has had to execute multiple reverse stock splits, including a 1-for-8 split in March 2026 and a 1-for-31 split in June 2026. Furthermore, the company operates via a complex Variable Interest Entity (VIE) structure that is subject to strict and unpredictable Chinese regulatory oversight, presenting substantial structural risks to foreign investors. Given the continuous dilution from recent public offerings and warrants, along with deteriorating financial performance, a Strong Sell recommendation is warranted. This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today. Our research · scenarios, merits, risks, and invalidation triggersResearch as of 20 Jun 2026 Scenarios · 12-month scenario targets Bear CaseDownside scenario PRC regulatory authorities challenge or disallow the VIE contractual arrangements, completely disrupting operations and rendering the Class A ordinary shares worthless. Alternatively, further deterioration in financial performance and failure to maintain the Nasdaq minimum bid price leads to delisting to the OTC market, severely limiting liquidity. Base CaseCentral scenario The company continues to struggle with declining demand for its healthcare information and MDMOOC services in China. Revenue remains depressed under $12 million, and net losses persist due to high operational costs and compliance expenses. The stock price remains highly volatile and trades under pressure, requiring ongoing capital raises that dilute existing shareholders. Bull CaseUpside scenario Zhongchao successfully leverages its platform-based internet technology to scale patient management services in oncology and rare diseases, driving high-margin revenue growth and achieving net profitability ahead of expectations, supported by a strong balance sheet with substantial cash reserves and minimal liabilities. Scenarios reflect our research view at the research date. Key Investment Merits
Key Investment Risks
Thesis Invalidation Triggers
All scenarios are estimates and subject to change. Past performance is not indicative of future results. Quality Pillars MembersThis section is available to registered members. Create a free account or sign in to unlock the full breakdown. Explore this dossierValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework. |